Abstract
A 39-year-old polytransfused patient with aplastic anemia acquired transfusion-associated HTLV-I infection shortly before transplantation. The patient underwent allogeneic bone marrow transplantation and developed HTLV-I associated myelopathy 3 years later. Clinical abnormalities and a host of atypical findings are presented in the context of previous reports describing uncommon features of the disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Emmanouilides, C., Territo, M. HTLV-I-associated myelopathy following allogeneic bone marrow transplantation. Bone Marrow Transplant 24, 205–206 (1999). https://doi.org/10.1038/sj.bmt.1701864
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701864
Keywords
This article is cited by
-
Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients
Retrovirology (2016)
-
HTLV-1-associated myelopathy/tropical spastic paraparesis
Nature Reviews Disease Primers (2015)
-
Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision
Bone Marrow Transplantation (2013)
-
Current Status of Therapeutic Approaches to Adult T-Cell Leukemia
International Journal of Hematology (2003)